S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
LON:AGL

ANGLE (AGL) Share Price, News & Analysis

GBX 12.36
+0.11 (+0.87%)
(As of 04:32 AM ET)
Today's Range
12.36
12.50
50-Day Range
12.25
19.50
52-Week Range
9.07
37.40
Volume
20,858 shs
Average Volume
3.56 million shs
Market Capitalization
£32.20 million
P/E Ratio
N/A
Dividend Yield
1.12%
Price Target
GBX 120

ANGLE MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
879.6% Upside
GBX 120 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.86 out of 5 stars

AGL stock logo

About ANGLE Stock (LON:AGL)

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.

AGL Stock Price History

AGL Stock News Headlines

Angles, lines and polygons - Edexcel
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Angle PLC Announces Breakthrough Clinical Results
ANGLE Plc Signs Contract With Eisai - Quick Facts
Angle PLC - Contract announcement with Eisai Inc.
Angle PLC Announces Broker Announcement
Angles and triangles
ANGLE launches Portrait+ CTC kit at SABCS
ANGLE unveils new detailed cancer diagnostic
Agree Realty Corp AGL
Angle PLC Announces Trading and Business Update
ANGLE technology showcased in poster presentations at cancer event
See More Headlines
Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGLE and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/30/2020
Today
3/27/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
173
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 120
High Stock Price Target
GBX 120
Low Stock Price Target
GBX 120
Potential Upside/Downside
+871.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
£-22,280,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.82 million
Cash Flow
GBX 2.13 per share
Book Value
GBX 12 per share

Miscellaneous

Free Float
N/A
Market Cap
£32.20 million
Optionable
Not Optionable
Beta
0.20
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Andrew David William Newland ACA (Age 63)
    Meng, Founder, CEO & Executive Director
    Comp: $264k
  • Mr. Ian Francis Griffiths ACA (Age 60)
    BA, CFO, Finance Director, Company Secretary & Executive Director
    Comp: $164k
  • Mr. Martin Cooke (Age 55)
    Director of Operations & Regulatory Affairs
  • Dr. Karen Miller Ph.D.
    Chief Scientific Officer
  • Mr. Andrew John Holder (Age 56)
    Head of Investor Relations
  • Ms. Anne-Sophie Pailhes-Jimenez
    Head of R&D and Senior Director
  • Mr. Brett Swansiger
    Chief Commercial Officer
  • Mr. Nick Claxton
    Senior Vice President of Commercial Operations

AGL Stock Analysis - Frequently Asked Questions

Should I buy or sell ANGLE stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ANGLE in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AGL shares.
View AGL analyst ratings
or view top-rated stocks.

What is ANGLE's stock price target for 2024?

1 analysts have issued 1 year price targets for ANGLE's stock. Their AGL share price targets range from GBX 120 to GBX 120. On average, they anticipate the company's share price to reach GBX 120 in the next year. This suggests a possible upside of 879.6% from the stock's current price.
View analysts price targets for AGL
or view top-rated stocks among Wall Street analysts.

How have AGL shares performed in 2024?

ANGLE's stock was trading at GBX 11.75 at the start of the year. Since then, AGL stock has increased by 4.3% and is now trading at GBX 12.25.
View the best growth stocks for 2024 here
.

How were ANGLE's earnings last quarter?

ANGLE plc (LON:AGL) announced its quarterly earnings data on Thursday, January, 30th. The company reported ($3.33) earnings per share for the quarter.

What other stocks do shareholders of ANGLE own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ANGLE investors own include Yamana Gold (YRI), Asiamet Resources (ARS), Dekel Agri-Vision (DKL), Eldorado Gold (ELD), Polo Resources (POL), Silvercorp Metals (SVM), First Majestic Silver (AG), AFPO.L (AFPO), Ariana Resources (AAU) and Alamos Gold (AGI).

How do I buy shares of ANGLE?

Shares of AGL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:AGL) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners